+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East & Africa Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

  • PDF Icon

    Report

  • 150 Pages
  • April 2025
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 6109132
Description Jump to:
The Middle East & Africa cell and gene therapy market was valued at US$ 129.17 million in 2023 and is projected to reach US$ 469.34 million by 2031; it is estimated to record a CAGR of 17.5% from 2023 to 2031.

Automation of Cell and Gene Therapy Manufacturing Services Boosts Middle East & Africa Cell and Gene Therapy Market

Incorporating automation in cell and gene therapy manufacturing can lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices designed to boost the automation of most sequential unit operations for a CAR-T process within a single system. With the rise in demand for cell and gene therapies, the production of cell and gene therapy products has shifted from a small-volume process to a large-volume process worldwide. In addition to the increasing research activities, the evolution of cell and gene therapy from an academic and clinical setting to commercialization has propelled the demand for automation in commercial manufacturing. Further, government agencies are adopting automation in the manufacturing of cell therapies to increase national production capabilities. Thus, automation of cell and gene therapy manufacturing services is expected to bring new trends in the Middle East & Africa cell and gene therapy market in the coming years.

Middle East & Africa Cell and Gene Therapy Market Overview

South Africa is a developing nation. The proper implementation of a cell therapy program in South Africa can result in the reduction of the high disease burden in the country; however, the cost of cell and gene therapy restricts South African patients' access to these therapies. Despite being technologically more advanced than other African nations, gene therapy manufacturing is still not widely available in South Africa. The most problematic aspects are the lack of funding, human resources, and awareness about therapy. Although the South African government has made efforts to support the biotechnology industry, cell therapy has not received enough attention. Moreover, the scientific and medical community is highly innovative and focused on cell and gene therapy.

Middle East & Africa Cell and Gene Therapy Market Segmentation

The Middle East & Africa cell and gene therapy market is categorized into type, services, scale, end user, and country.

Based on type, the Middle East & Africa cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.

In terms of services, the Middle East & Africa cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.

By scale, the Middle East & Africa cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.

Based on end user, the Middle East & Africa cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Middle East & Africa cell and gene therapy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa cell and gene therapy market share in 2023.

Catalent Inc, Charles River Laboratories International Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc., and WuXi AppTec Co Ltd are some of the leading companies operating in the Middle East & Africa cell and gene therapy market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa cell and gene therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa cell and gene therapy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Middle East & Africa Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Middle East & Africa Cell and Gene Therapy Market - Key Market Dynamics
5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market -Middle East & Africa Market Analysis
6.1 Overview Middle East and Africa Cell and Gene Therapy Market Overview
6.2 Middle East & Africa Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.3 Cell and Gene Therapy Market Forecast Analysis
7. Middle East & Africa Cell and Gene Therapy Market Analysis - by Type
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Cell and Gene Therapy Market Analysis - by Services
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Cell and Gene Therapy Market Analysis - by Scale
9.1 Pre-Commercial/R&D Manufacturing
9.1.1 Overview
9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Cell and Gene Therapy Market Analysis - by Service Providers
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Cell and Gene Therapy Market Analysis - by End User
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12. Middle East & Africa Cell and Gene Therapy Market - Country Analysis
12.1 Middle East and Africa Cell and Gene Therapy Market, by Key Country - Revenue (2023) (US$ Million)
12.1.1 Middle East and Africa Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
12.1.1.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
12.1.1.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.1.1.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.1.1.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.1.1.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.1.1.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.1.1.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.1.1.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lonza Group AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 WuXi AppTec Co Ltd
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Takara Bio Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corp
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. Hoffmann-La Roche Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Catalent Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Lotte Corp
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 34. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 35. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 36. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 37. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 38. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 39. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 40. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 41. Glossary of Terms
List of Figures
Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Middle East and Africa Cell and Gene Therapy Market, by Key Country- Revenue (2023) (US$ Million)
Figure 24. Middle East and Africa Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. Growth Strategies in Cell and Gene Therapy Market

Companies Mentioned

Some of the leading companies in the Middle East & Africa Cell and Gene Therapy Market include:
  • Catalent Inc
  • Charles River Laboratories International Inc
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corp
  • Lonza Group AG
  • Lotte Corp
  • Merck KGaA
  • Takara Bio Inc
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co Ltd

Table Information

Report AttributeDetails
No. of Pages150
PublishedApril 2025
Forecast Period2023 - 2031
Estimated Market Value in 2023 129.17 Million in 2023
Forecasted Market Value by 2031 469.34 Million by 2031
Compound Annual Growth Rate17.5%
Regions CoveredAfrica, Middle East
No. of Companies Mentioned11

Related Topics

Related Reports

Cell and Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User and Geography - Product Image

Cell and Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User and Geography

  • Report
  • 232 Pages
  • Global
From
Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography - Product Image

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography

  • Report
  • 249 Pages
  • Global
From
Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 - Product Image

Cell and Gene Therapy Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • Report
  • 115 Pages
  • Global
From
Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors, Indication, Delivery Mode, and Geography - Product Image

Gene Therapy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors, Indication, Delivery Mode, and Geography

  • Report
  • 150 Pages
  • Global
From
Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031 - Product Image

Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • Report
  • 112 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.